United States: HHS Proposes Rule To Eliminate Safe Harbor For PBM Drug Rebates

Last Updated: February 18 2019
Article by Ken Yood and Melissa R. Gertler

On February 6, 2019, the Office of the Inspector General of the U.S. Department of Health and Human Services (the "OIG") published in the Federal Register a proposed rule (the "Proposed Rule") that, if made final in its current form, would (i) amend the Anti-kickback Statute ("AKS") Discount Safe Harbor to explicitly exclude discounts relating to price reductions or other remuneration offered by a pharmaceutical manufacturer to a Medicare Part D plan sponsor ("Plan Sponsor"), a Medicaid managed care organization ("MCO"), and/or a pharmacy benefit manager ("PBM") under contract with such a sponsor or organization; and (ii) add two new safe harbors: a "Discounts Offered at the Point-of-Sale" safe harbor ("Point of Sale Safe Harbor") and a PBM Fee Arrangement Safe Harbor ("PBM Safe Harbor").

The Proposed Rule is the latest salvo by the Trump Administration against what the President has stated – such statements include those made most recently by the President in the State of the Union address on February 5, 2019 – is one of the most significant healthcare challenges faced by the public today: inflated prescription drug list prices and exorbitant out-of-pocket costs experienced by patients when purchasing prescribed drugs. If one were asked to identify the specific targets of the Proposed Rule, the likely contenders would be the drug manufacturers and PBMs.

As described by Alex Azar, Secretary of the U.S. Department of Health and Human Services, in the Trump Administration's May 2018 American Patients First plan, "when it comes to the cost of pre-scription drugs, our healthcare sys¬tem faces four major challenges: high list prices for drugs; seniors and gov¬ernment programs overpaying for drugs due to lack of the latest nego¬tiation tools; high and rising out-of¬-pocket costs for consumers; and for¬eign governments free-riding off of American investment in innovation." As mentioned above, the Proposed Rule is primarily focused on two of these challenges – high list prices and rising out-of-pocket costs.

Transparency. In the Preamble to the Proposed Rule, the OIG observes that current pharmaceutical manufacturer discount practices are not transparent. The OIG notes that, "[i]n some or many instances, plan sponsors under Medicare Part D and Medicaid MCOs have limited information about the percentage of rebates passed on to them and the percentage retained by their PBMs. The terms of rebate agreements manufacturers negotiate with PBMs may be treated as highly proprietary and, in many instances, may be unavailable to the plans." In turn, the OIG concludes that, "this lack of transparency creates significant compliance risks for Medicaid MCOs and Medicare Part D plan sponsors who are obligated to "disclose, report, and otherwise account accurately for rebates where required by program rules (and potentially, under the discount safe harbor)." By impeding such disclosures, the OIG concludes that the lack of transparency, "creates a potential program integrity vulnerability because compliance with program rules may be more difficult to verify.

The Safe Harbor Regulations – Revisions and Additions. In addition to the aims of improving transparency and ameliorating the above described compliance risks identified by the OIG, the Proposed Rule is intended to lower drug list prices and consumer out-of-pocket expenses by providing safe harbor protection to those arrangements which pass the savings of a manufacturer discount along to consumers. To accomplish this feat, the Proposed Rule revises the Discount Safe Harbor and proposes two new safe harbors – the Point of Sale Safe Harbor and the PBM Safe Harbor.

The Discount Safe Harbor. As described in the Preamble to the Proposed Rule, the Proposed Rule, if finalized in its current form, would amend the Discount Safe Harbor so that it would no longer protect price reductions from manufacturers to Plan Sponsors or Medicaid MCOs, either directly or through PBMs acting under contract with Plan Sponsors or Medicaid MCOs, unless the reduction in price is required by law. In addition, the Discount Safe Harbor amendment would define the term, "plan sponsor under Medicare Part D" to include both sponsors of Medicare prescription drug plans and sponsors of Medicare Advantage prescription drug plans.

According to the OIG, the Discount Safe Harbor amendments are not intended to interfere with manufacturer discounts on products that are offered to entities such as wholesalers, hospitals and providers – i.e., not discounts offered to individuals to purchase prescribed pharmaceuticals. Moreover, the OIG writes that it does not intend for the proposed amendment to have any impact on existing protections for value-based arrangements between manufactures and Plan Sponsors.

Point of Sale Safe Harbor. Subject to the satisfaction of certain enumerated criteria, the proposed Point of Sale Safe Harbor is intended to protect arrangements that include point-of-sale price reductions offered by manufacturers on certain pharmaceutical products that are payable under Medicare Part D or by Medicaid MCOs. Such criteria include the following (i) any price reduction arrangement between a manufacturer and a Plan Sponsor or a PBM be set in advance, (ii) in order to be considered a "rebate" subject to safe harbor protection, a manufacturer price reduction arrangement must allow a dispensing pharmacy to receive the full value of the price reduction through a chargeback or a series of chargebacks or as otherwise required by law; and (iii) the manufacturer's price reduction that has been passed to the dispensing pharmacy must be entirely passed through to consumers at the time that they receive their medications from the dispensing pharmacy – i.e., at the point of sale.

PBM Safe Harbor. The PBM Safe Harbor is intended to protect certain fixed fee arrangements between manufacturers and PBMs, so long as such arrangements meet certain criteria. Such criteria include that the fee arrangement is disclosed in writing to each applicable health plan, and the fee arrangement "relate[s] in some way" to the PBM's arrangements with health plans to provide pharmacy benefit management services.

The Potential Impact. If the Proposed Rule goes into effect, PBMs may be more vulnerable to AKS enforcement actions for discounts that they negotiate with drug manufacturers. In addition, the Pharmaceutical Care Management Association has expressed concern that eliminating rebates could increase drug prices and force Medicare beneficiaries to pay higher premiums and out-of-pocket costs in order to access the prescription drugs they need.

The OIG is currently seeking feedback on the Proposed Rule. Comments are due by April 8, 2019. Once the rule is finalized, the OIG plans to implement the new safe harbors within 60 days of finalization and to amend the existing Discount Safe Harbor as of January 1, 2020.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Events from this Firm
17 Oct 2019, Seminar, San Diego, United States

Please join us for Sheppard Mullin's Labor & Employment Law Update & Happy Hour Seminar Series. There are many new developments in California labor and employment laws that will significantly affect the way you run your day-to-day business operations.

22 Oct 2019, Roundtable, Los Angeles, United States

Please join us for Sheppard Mullin's Ethics and Eggs: A Breakfast Roundtable to Discuss Ethics Issues in IP Matters.

23 Oct 2019, Other, Dallas, United States

Marketing Wants To Do What? Sweepstakes, Influencers, Loyalty, and Other Advertising and Promotional Fun

Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions